跳至主要内容
临床试验/NCT07496762
NCT07496762尚未招募不适用

Effects of Different-Frequency Electroacupuncture on Suprahyoid Muscles in Post-Stroke Dysphagia: Efficacy and Neural Networks

Kaili Chen1 个研究点 分布在 1 个国家目标入组 102 人开始时间: 2026年12月21日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
102
试验地点
1
主要终点
Change in Water Swallow Test (WST) Score

研究概览

简要总结

This randomized controlled study in patients with post-stroke dysphagia aims to determine the optimal stimulation frequency of electroacupuncture of the suprahyoid muscles and to elucidate the underlying neural mechanisms. Participants will be assigned to low-frequency (2 Hz), medium-frequency (50 Hz), or high-frequency (100 Hz) electroacupuncture groups. Therapeutic efficacy will be assessed using the Kubota water-drinking test, videofluoroscopic swallowing study (VFSS), and ultrasonography to identify the optimal frequency. In parallel, diffusion tensor imaging (DTI) will be used to evaluate changes in fiber connectivity between swallowing-related cortical regions (bilateral precentral gyrus, insula, supramarginal gyrus, and frontal lobe) and the medullary nucleus tractus solitarius, thereby exploring neural network remodeling and providing mechanistic evidence to inform clinical practice.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Diagnosis: Patients diagnosed with cerebral infarction confirmed by CT or MRI.
  • •Dysphagia Screening: Presence of varying degrees of dysphagia as screened by the Water Swallow Test (WST).
  • •Clinical Status: Conscious and stable vital signs, with the ability to cooperate with the treatment.
  • •Age: Aged between 18 and 80 years.
  • •Consent: Signed informed consent form obtained from the patient or their legal representative.

排除标准

  • •Dysphagia Etiology: Patients with dysphagia caused by etiologies other than cerebral infarction.
  • •MRI Contraindications: Patients with metal implants or pacemakers in the body (contraindications for MRI).
  • •Bleeding Risk: Patients with bleeding tendencies or coagulation disorders.
  • •Blood Pressure: Patients with uncontrolled hypertension (systolic blood pressure > 180 mmHg or diastolic blood pressure > 120 mmHg).
  • •Organ Failure: Patients with severe failure of vital organs (e.g., heart, liver, or kidney failure).
  • •Disease Severity: Patients with critical or life-threatening stroke conditions.
  • •Cooperation: Patients unable to cooperate with the treatment due to severe cognitive impairment, aphasia, or other reasons.

研究组 & 干预措施

Low Frequency EA

Experimental

Participants will receive electroacupuncture on the suprahyoid muscles at a frequency of 2Hz. The intensity should be adjusted to the patient's tolerance, utilizing a discontinuous waveform. Treatment is administered once daily for 30 minutes, with a course cosisting of 7 sessions. A rest day is observed between courses, and the treatment is continued for a total of 6 courses.

干预措施: Low Frequency EA (Device)

Medium Frequency EA

Experimental

Participants will receive electroacupuncture on the suprahyoid muscles at a frequency of 50Hz.The intensity should be adjusted to the patient's tolerance, utilizing a discontinuous waveform. Treatment is administered once daily for 30 minutes, with a course cosisting of 7 sessions. A rest day is observed between courses, and the treatment is continued for a total of 6 courses.

干预措施: Medium Frequency EA (Device)

High Frequency EA

Experimental

Participants will receive electroacupuncture on the suprahyoid muscles at a frequency of 100Hz. The intensity should be adjusted to the patient's tolerance, utilizing a discontinuous waveform. Treatment is administered once daily for 30 minutes, with a course cosisting of 7 sessions. A rest day is observed between courses, and the treatment is continued for a total of 6 courses.

干预措施: High Frequency EA (Device)

结局指标

主要结局

Change in Water Swallow Test (WST) Score

时间窗: Baseline and Week 6 (End of treatment)

The WST is a screening tool for dysphagia. It assesses the ability to swallow water and the presence of coughing or choking. Scores range from 1 to 5, with higher scores indicating more severe dysphagia. Improvement is defined as a decrease in the WST score.

次要结局

  • Change in Penetration-Aspiration Scale (PAS) Score via VFSS(Baseline and Week 6 (End of treatment))
  • Hyolaryngeal excursion measured by Ultrasound(Baseline and Week 6 (End of treatment))
  • Changes in Fractional Anisotropy (FA) values of swallowing-related neural pathways(Baseline and Week 6 (End of treatment))

研究者

发起方
Kaili Chen
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Kaili Chen

resident physician

The Third Affiliated hospital of Zhejiang Chinese Medical University

研究点 (1)

Loading locations...

相似试验